There are 702 resources available
Optimising drug development in GI oncology: Look first at the science behind! The pharma perspective
Presenter: Nicola Valeri
Session: EORTC session: Hot topics and methodological perspectives in GI oncology trials
Resources:
Slides
Webcast
Precision medicine and bile duct cancer
Presenter: Rachna Shroff
Session: Cancer of the bile ducts
Resources:
Slides
Webcast
Q&A
Presenter: Irit Ben-Aharon
Session: Early onset GI cancer
Resources:
Webcast
Mind the methods: Novel designs for GI cancer clinical trials
Presenter: Murielle Mauer
Session: EORTC session: Hot topics and methodological perspectives in GI oncology trials
Resources:
Slides
Webcast
Q&A
Presenter: Angela Lamarca
Session: Cancer of the bile ducts
Resources:
Webcast
Here we are again: Bevacizumab or anti-EGFR monoclonal antibodies for upfront unresectable, left-sided, colorectal cancer liver metastases? Pro anti-EGFR
Presenter: Gunnar Folprecht
Session: EORTC session: Hot topics and methodological perspectives in GI oncology trials
Resources:
Slides
Webcast
Here we are again: Bevacizumab or anti-EGFR monoclonal antibodies for upfront unresectable, left-sided, colorectal cancer liver metastases? Pro bevacizumab
Presenter: Francesco Sclafani
Session: EORTC session: Hot topics and methodological perspectives in GI oncology trials
Resources:
Slides
Webcast
Welcome and introduction
Presenter: Salah-Eddin Al-Baltran
Session: Astellas - Lighting the path ahead: The future of precision medicine in gastric and gastro-oesophageal junction adenocarcinoma
Resources:
Webcast
Welcome and introduction
Presenter: David Malka
Session: PeerVoice - Providing cutting-edge care for cholangiocarcinoma: Transforming the patient journey
Resources:
Webcast
Is light breaking through? The future for the management of G/GEJ adenocarcinoma
Presenter: Salah-Eddin Al-Baltran
Session: Astellas - Lighting the path ahead: The future of precision medicine in gastric and gastro-oesophageal junction adenocarcinoma
Resources:
Webcast